skip to main content

DOE PAGESDOE PAGES

This content will become publicly available on March 26, 2019

Title: The antimalarial compound ELQ-400 is an unusual inhibitor of the bc 1 complex, targeting both Q o and Q i sites

Authors:
 [1] ;  [2] ;  [3] ;  [4] ;  [3]
  1. Translational Research Institute, Henan Provincial People's Hospital, School of Medicine, Henan University, Zhengzhou China, Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette France
  2. Institut de Chimie des Substances Naturelles, CNRS, UPR 2301, Labex LERMIT, Université Paris-Saclay, Gif-sur-Yvette France
  3. Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette France
  4. MSU-DOE Plant Research Laboratory, Michigan State University, East Lansing MI USA
Publication Date:
Grant/Contract Number:
FG02-11ER16220
Type:
Publisher's Accepted Manuscript
Journal Name:
FEBS Letters
Additional Journal Information:
Journal Volume: 592; Journal Issue: 8; Related Information: CHORUS Timestamp: 2018-04-30 07:01:51; Journal ID: ISSN 0014-5793
Publisher:
Wiley Blackwell (John Wiley & Sons)
Sponsoring Org:
USDOE
Country of Publication:
Netherlands
Language:
English
OSTI Identifier:
1429930